https://pmc.ncbi.nlm.nih.gov/articles/PMC4022916/
Hydroxyurea in Sickle Cell Disease: Drug Review - PMC
Hydroxyurea, a myelosuppressive agent, is the only effective drug proven to reduce the frequency of painful episodes. It raises the level of HbF and the...
sickle cell diseasedrug reviewhydroxyureapmc
https://digitalcollections.library.oregon.gov/nodes/view/35603
Oregon's drug review [ Evidence on ACEIs (angiotensin converting enzyme inhibitors)] | State...
Date: 2004 | Collection: Administrative Services | Read the full record details for State Publication: Oregon's drug review [ Evidence on ACEIs (angiotensin...
angiotensin converting enzymedrug review
https://www.fda.gov/drugs/electronic-regulatory-submission-and-review/transcript-data-standards-improving-drug-review
Transcript: Data Standards: Improving Drug Review | FDA
data standardsdrug reviewtranscriptimprovingfda
https://www.gsk.com/en-gb/media/press-releases/gsk-announces-extension-of-us-food-and-drug-administration-review-period-for-blenrep-belantamab-mafodotin-blmf-in-relapsedrefractory-multiple-myeloma/
GSK announces extension of US Food and Drug Administration review period for Blenrep (belantamab...
New PDUFA date scheduled for 23 October 2025.
food and drug administration
https://pmc.ncbi.nlm.nih.gov/articles/PMC12663523/
Release mechanisms of PLGA-based drug delivery systems: A review - PMC
Poly(lactic-co-glycolic acid) (PLGA)-based microparticles and implants are of continuously increasing importance as parenteral controlled drug delivery...
drug delivery systemsrelease mechanismsplgabased
https://researchdiscovery.drexel.edu/esploro/outputs/journalArticle/Re-A-systematic-review-of-drug/991019350583704721
Re: A systematic review of drug treatment of vulvodynia: evidence of a strong placebo effect -...
Re: A systematic review of drug treatment of vulvodynia: evidence of a strong placebo effect - Drexel University - Journal article
systematic reviewdrug treatment
https://health.economictimes.indiatimes.com/news/pharma/bristol-myers-says-u-s-fda-extends-review-of-heart-disease-drug/87812902
Bristol Myers says U.S. FDA extends review of heart disease drug, ETHealthworld
The regulator is now set to take a decision on the drug by April 28 next year, Bristol Myers said.
https://open.bu.edu/items/dd293b21-a81d-48d0-afe2-af0ee658e6ba
Children of female sex workers and drug users: a review of vulnerability, resilience and...
BACKGROUND Injection drug users and female sex workers are two of the populations most at risk for becoming infected with HIV in countries with concentrated...
female sex workers
https://www.mdpi.com/1424-8247/3/4/1187
A Review of Anti-Inflammatory Drug-Induced Gastrointestinal Injury: Focus on Prevention of Small...
Capsule endoscopy and balloon endoscopy, advanced modalities that allow full investigation of the entire small intestine, have revealed that nonsteroidal...
https://oig.justice.gov/reports/review-drug-enforcement-administrations-use-cold-consent-encounters-mass-transportation
Review of the Drug Enforcement Administration's Use of Cold Consent Encounters at Mass...
Inspection / Evaluation